Oral versus vaginal misoprostol for labor induction

Area of Science:

• Obstetrics and Gynecology
• Pharmacology

Background:

• Labor induction is a common obstetric procedure.
• Misoprostol is widely used for cervical ripening and labor induction.
• Different routes of administration (oral vs. vaginal) may affect safety and efficacy.

Purpose of the Study:

• To compare the safety and effectiveness of oral versus vaginal misoprostol for labor induction.
• To evaluate key maternal and neonatal outcomes between the two administration routes.

Main Methods:

• Randomized controlled trial involving 107 women requiring labor induction.
• Women were assigned to receive either oral (100 microg) or vaginal (25 microg) misoprostol every 3-4 hours.
• Doses were adjusted based on cervical ripening and labor progression.

Main Results:

• No significant difference in delivery time between oral and vaginal misoprostol groups (P =.11).
• Similar cesarean delivery rates (17% vaginal vs. 15% oral, P =.72).
• Comparable rates of chorioamnionitis, tachysystole, and neonatal outcomes between groups.

Conclusions:

• Oral misoprostol is a safe and effective alternative to vaginal misoprostol for labor induction.
• Close hospital supervision and monitoring are crucial for safe administration.
• Findings support the use of oral misoprostol in clinical practice for labor induction.